cagrilintide-semaglutide Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study Coadministered Cagrilintide and Semaglutide, in

Each pen of BPC-157 + TB-500 (Blend) contains 200 units

This synthetic peptide acts as a triple incretin receptor agonist, hitting the GLP-1, GIP and glucagon receptors in parallel a mechanism that places it among the most intricate agonists available for preclinical metabolic signalling work

A study that looked at 0.5-1mg/kg/day leucovorin in patients with cerebral folate deficiency (and related neurological symptoms) found that 90% of those supplemented achieved normal 5-methyltetrahydrofolate cerebral spinal fluid concentrations

From weight loss (like Tirzepatide) to injury recovery (like BPC-157), our Houston peptide therapy programs are physician-directed, FDA-regulated, and tailored to your goals

state boards publish disciplinary records

The BPC-157 + TB-500 20mg vial is a single lyophilized vial combining BPC-157 with TB-500 (Thymosin Beta-4 fragment)